Erik Anders Kronström
Chief Operating Officer en INFANT BACTERIAL THERAPEUTICS AB .
Fortuna: 89 953 $ al 30/04/2024
Cargos activos de Erik Anders Kronström
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Chief Operating Officer | 01/01/2018 | - |
| Chief Tech/Sci/R&D Officer | 20/10/2014 | 01/01/2018 |
Historial de carrera de Erik Anders Kronström
Antiguos cargos conocidos de Erik Anders Kronström.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Chief Executive Officer | - | - |
Formación de Erik Anders Kronström.
| Warwick Business School | Masters Business Admin |
| Royal Institute of Technology | Graduate Degree |
Estadísticas
Internacional
| Suecia | 3 |
| Reino Unido | 2 |
| Noruega | 2 |
Operativa
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
| Empresas privadas | 1 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
